Akebia Therapeutics (AKBA) Earnings
|
Expand Research on AKBA
| Next EPS Date | 11/9/23 | EPS Growth Rate | +76.5% |
|---|---|---|---|
| Average EPS % Beat Rate | -68.5% | Revenue Growth Rate | +0.9% |
| Average % Move 1-Wk after EPS | +1.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/9/23 | Q323 | N/A | -$0.08 | N/A | N/A | $49.18M | N/A | N/A | N/A | ||
| 8/10/23 | Q223 | N/A | -$0.03 | N/A | N/A | $59.1M | N/A | N/A | N/A | ||
| 8/14/23 | Q223 | N/A | -$0.03 | N/A | N/A | $59.1M | N/A | N/A | N/A | ||
8/25/23  |
Q223 | -$0.06 | -$0.03 | -$0.03 | $56.4M | $59.1M | N/A |  | | Details | |
| 5/8/23 |
Q123 | N/A | -$0.15 | N/A | N/A | $46.7M | N/A | N/A | N/A | ||
| 3/9/23 | Q422 | N/A | -$0.18 | N/A | N/A | $48.35M | = | N/A | N/A | ||
| 11/3/22 | Q322 | -$0.34 | -$0.18 | -$0.16 | $48.76M | $48.91M | = | | | Details | |
| 8/4/22 | Q222 | -$0.51 | -$0.31 | -$0.20 | $52.91M | $52.52M | = | | | Details |
